Thank you for visiting the ENRICH Study Publications Page. The main ENRICH study is due to conclude in June 2024 and we expect to publish our findings here from January 2025 onwards
ENRICH study findings
A randomised, open label study of Rituximab/Ibrutinib vs Rituximab/Chemotherapy in older patients with untreated mantle cell lymphoma.
